Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial - Kasner, S E; Swaminathan, B; Lavados, P (Lancet Neurol, 2018)
et al.